Incannex Executes License Agreement with Monash University to Develop a Combination Treatment Using Virtual Reality and Psychedelics

Incannex Healthcare has announced it has executed a license agreement with Monash University to develop a novel treatment that combines Virtual Reality and psychedelics. This marks the initiation of a second clinical psychedelic therapy program.

Category Press Release
Published in Yahoo Finance

Companies Featured

Incannex Healthcare
Incannex Healthcare is a clinical-stage cannabinoid and psychedelic medicine developer.

Monash University
The Clinical Psychedelic Research Lab at Monash University is Australia's first research group dedicated to the study of psychedelics.

?>